Table 2

Patient groups	Number of cells in the embryo mean±SD	Morula stage n (%)	Embryo quality, grade A n (%)
Table 2. Characteristics of embryos transferred on day 3.
POSEIDON I n=50 <35Y, ≥1.2 ng/ml AMH	8.8±0.5	8 (16%)^a	23 (47%)^a
POSEIDON II n=40 ≥35Y, ≥1.2 ng/ml AMH	8±0.3	6 (15%)^a	16 (39)^a
POSEIDON III n=63 <35Y, <1.2 ng/ml AMH	8.1±0.7	6 (10%)^b	16 (25)^b
POSEIDON IV n=89 ≥35Y, <1.2 ng/ml AMH	8.1±0.5	8 (9%)^b	24 (27)^b
Non-POSEIDON <35y, n=39	8.2±0.2	6 (15%)^a	16 (41%)^a
Non-POSEIDON ≥35y, n=49	8.1±0.7	7 (15%)^a	15 (30%)^b
Total n=330	8.1±0.5	36 (12%)	107 (32%)

^a:b values with different superscripts within the same column differ significantly (p<0.05).